Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
100% APRP vs 100% AS in Moderate to Severe Dry Eye Disease
NCT04683796Phase 3Completed
- Sponsor
- Mahidol University
- Start
- Feb 2021
- Primary completion
- Feb 2023
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 3 trial of autologous platelet-rich plasma in dry eye disease (DED), sponsored by Mahidol University. Started Feb 2021; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04683796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04683796.